These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 21664961)

  • 1. Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists.
    Peri F; Piazza M
    Biotechnol Adv; 2012; 30(1):251-60. PubMed ID: 21664961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the LPS/TLR4 signal pathway with small molecules.
    Peri F; Piazza M; Calabrese V; Damore G; Cighetti R
    Biochem Soc Trans; 2010 Oct; 38(5):1390-5. PubMed ID: 20863319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 4 initiates an innate immune response to lipopolysaccharide in human conjunctival epithelial cells.
    Chung SH; Kweon MN; Lee HK; Choi SI; Yang JY; Kim EK
    Exp Eye Res; 2009 Jan; 88(1):49-56. PubMed ID: 18951893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid differentiation 2 as a therapeutic target of inflammatory disorders.
    Park SH; Kim ND; Jung JK; Lee CK; Han SB; Kim Y
    Pharmacol Ther; 2012 Mar; 133(3):291-8. PubMed ID: 22119168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells.
    Tsukamoto H; Fukudome K; Takao S; Tsuneyoshi N; Kimoto M
    Int Immunol; 2010 Apr; 22(4):271-80. PubMed ID: 20133493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
    Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
    Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of dermal fibroblasts as a predictive tool of the toll-like receptor 4 response pathway and its development in Holstein heifers.
    Green BB; Kandasamy S; Elsasser TH; Kerr DE
    J Dairy Sci; 2011 Nov; 94(11):5502-14. PubMed ID: 22032373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate recognition of lipopolysaccharide by Toll-like receptor 4/MD-2 and RP105/MD-1.
    Miyake K; Ogata H; Nagai Y; Akashi S; Kimoto M
    J Endotoxin Res; 2000; 6(5):389-91. PubMed ID: 11521060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model.
    Cyr SL; Angers I; Guillot L; Stoica-Popescu I; Lussier M; Qureshi S; Burt DS; Ward BJ
    Vaccine; 2009 Jan; 27(3):421-30. PubMed ID: 19013492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance.
    Calvano JE; Agnese DM; Um JY; Goshima M; Singhal R; Coyle SM; Reddell MT; Kumar A; Calvano SE; Lowry SF
    Shock; 2003 Nov; 20(5):415-9. PubMed ID: 14560104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of myeloid differential protein-2 in innate immunity].
    Xu FL; Li L
    Sheng Li Ke Xue Jin Zhan; 2004 Apr; 35(2):139-42. PubMed ID: 15285420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R-form LPS, the master key to the activation ofTLR4/MD-2-positive cells.
    Huber M; Kalis C; Keck S; Jiang Z; Georgel P; Du X; Shamel L; Sovath S; Mudd S; Beutler B; Galanos C; Freudenberg MA
    Eur J Immunol; 2006 Mar; 36(3):701-11. PubMed ID: 16506285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual roles of NOD2 in TLR4-mediated signal transduction and -induced inflammatory gene expression in macrophages.
    Tsai WH; Huang DY; Yu YH; Chen CY; Lin WW
    Cell Microbiol; 2011 May; 13(5):717-30. PubMed ID: 21199260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal peptide suppresses toll-like receptor 4 expression in macrophages via Akt1 reducing their responsiveness to lipopolysaccharide.
    Arranz A; Androulidaki A; Zacharioudaki V; Martinez C; Margioris AN; Gomariz RP; Tsatsanis C
    Mol Immunol; 2008 May; 45(10):2970-80. PubMed ID: 18336909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The induction of innate and adaptive immunity by biodegradable poly(γ-glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathway.
    Uto T; Akagi T; Yoshinaga K; Toyama M; Akashi M; Baba M
    Biomaterials; 2011 Aug; 32(22):5206-12. PubMed ID: 21492934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MD-2.
    Visintin A; Iliev DB; Monks BG; Halmen KA; Golenbock DT
    Immunobiology; 2006; 211(6-8):437-47. PubMed ID: 16920483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial endotoxin (lipopolysaccharide) stimulates interleukin-6 production and inhibits growth of pituitary tumour cells expressing the toll-like receptor 4.
    Tichomirowa M; Theodoropoulou M; Lohrer P; Schaaf L; Losa M; Uhl E; Lange M; Arzt E; Stalla GK; Renner U
    J Neuroendocrinol; 2005 Mar; 17(3):152-60. PubMed ID: 15796767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of a dimeric monosaccharide lipid A mimic and its synergistic effect on the immunostimulatory activity of lipopolysaccharide.
    Lewicky JD; Ulanova M; Jiang ZH
    Carbohydr Res; 2011 Sep; 346(13):1705-13. PubMed ID: 21689810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells.
    Allam JP; Peng WM; Appel T; Wenghoefer M; Niederhagen B; Bieber T; Bergé S; Novak N
    J Allergy Clin Immunol; 2008 Feb; 121(2):368-374.e1. PubMed ID: 18036651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism regulating cell surface expression and activation of Toll-like receptor 4.
    Saitoh S; Miyake K
    Chem Rec; 2006; 6(6):311-9. PubMed ID: 17304555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.